Fairvalue-Calculator Fairvalue-Calculator
EN DE

Chiyoda Co (CHYOF) Fair Value & Analysis

Consumer Cyclical · US · Market cap $275M

Price$8.10
Fair Value$9.38
Upside+15.8%
Quality95/100
Evidence: High Range $8.14 – $11.50

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Chiyoda Co (CHYOF) currently trades at $8.10, while our model-based Fair Value estimate is $9.38 — implying the stock looks roughly 15.8% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Chiyoda Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of shoes in Japan. It is also involved in the purchase and wholesale of shoes; and import of shoes and garments. The company operates stores under SHOE PLAZA, TOKYO SHOES RETAILING CENTER, CHIYODA HAKI-GOKOCHI, Chiyoda, cloverleaf, SPC, VifVif by cloverleaf, COURIPIE, and NATURA brand names. Chiyoda Co., Ltd. was founded in 1936 and is headquartered in Tokyo, Japan.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Chiyoda Co (CHYOF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $9.38 versus a price of $8.10 — about +16% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CHYOF?
Our 21-model fair value for Chiyoda Co is $9.38 (as of Jun 24, 2026), built from audited fundamentals. The current price is $8.10.
What is the quality score of CHYOF?
Chiyoda Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.